U.S. Semiconductors Stock News

Lyft (LYFT) just made a serious move into healthcare delivery, rolling out its Smart on FHIR App with VectorCare so hospitals can book and track patient rides directly inside Epic’s electronic health record system. See our latest analysis for Lyft. The market seems to like this healthcare push, with Lyft’s 90 day share price return of 29.7 percent and year to date share price return of 68.28 percent signaling building momentum despite a still mixed five year total shareholder return of...

Cleveland-Cliffs recently reported gains in steel output efficiency, using advanced automation, real-time monitoring, and energy management systems to optimize its production workflows across key end markets. This push to modernize operations could reshape the company’s cost base and competitive position in supplying steel to automotive, construction, and industrial machinery customers. Next, we’ll examine how Cleveland-Cliffs’ new production efficiency gains might influence its cost...

Kroger (KR) is back in the spotlight after a bruising third quarter, where strong e commerce growth and better margins were overshadowed by a surprise net loss and softer sales guidance that hit the stock. See our latest analysis for Kroger. The recent selloff, including a sharp post earnings drop and a 7.8% 90 day share price return, contrasts with Kroger’s steadier 8.0% one year total shareholder return. This suggests long term investors still see value as management leans into e commerce...

If you are wondering whether Fluence Energy is still a smart buy after its recent rally, you are not alone. This stock has quickly moved from a niche energy-storage play to a name that growth focused investors are debating on valuation grounds. Over the last week the share price has jumped 22.0%, adding to a 15.2% gain over the past month and a 41.7% rise year to date. The stock is now sitting around $23.96 and is up 41.6% over the past year, roughly 50.7% higher than three years ago. Part...

In its recent third-quarter update, Axsome Therapeutics reported a 63% year-over-year revenue increase driven mainly by strong Auvelity prescriptions and initial contributions from newly launched Symbravo, alongside higher Sunosi sales. While the company posted a wider-than-expected quarterly loss, investors are closely watching how reduced R&D spending and heavier commercial investment could reshape its path toward scaling its central nervous system portfolio. We’ll now examine how this...

Dillard's (DDS) just turned in its Q3 2026 scorecard with revenue of about $1.5 billion and basic EPS of $4.66 as investors weigh the latest read on the department store's profitability. The company has seen quarterly revenue move from roughly $1.51 billion and EPS of $4.59 in Q2 2025 to about $1.54 billion and EPS of $10.39 in Q1 2026 before landing at $1.54 billion and EPS of $4.66 in Q2 2026. This gives a clear sense of how earnings and sales have been oscillating around the same topline...

Rocket Lab Corporation recently announced that Japan’s space agency JAXA’s “RAISE And Shine” mission, the first of two dedicated Electron launches under a direct contract, will deploy the RAISE-4 technology demonstration satellite from Launch Complex 1 in New Zealand during a window that opened on December 5 UTC. These are Rocket Lab’s first dedicated Electron launches directly contracted with JAXA, highlighting the company’s growing role as a launch provider for major international space...

Wondering if Amgen at around $329 a share is still a smart buy, or if the upside has mostly been priced in already? You are not alone, and this article is going to unpack what that current price really implies. Despite a choppy week with a -4.5% move over the last 7 days, Amgen is still up 3.0% over the past month and a strong 27.2% year to date, with a 25.0% gain over 1 year and 69.8% over 5 years, a profile that hints at both growth potential and shifting market risk perceptions. Recent...

If you are staring at American Bitcoin and wondering whether this beaten down crypto stock is quietly turning into a value play, you are not alone. After a brutal slide, with the share price down about 47.4% over the last week, 51.9% over the last month, and 65.2% year to date, the big question now is whether the market has overshot on the downside or is still pricing in real risks. Recently, American Bitcoin has stayed in focus as traders reassess high beta crypto related names alongside...

Wondering if EPR Properties is still a buy after its recent run, or if you have already missed the best of the gains? This breakdown will help you decide whether the current price still stacks up against its fundamentals. The stock has climbed 22.5% over the last year and is up 17.4% year to date. The past week has been a modest -1.2% pullback and the last month only nudged 1.3% higher, which suggests sentiment is still broadly constructive but not euphoric. Recent headlines have focused on...

If you are wondering whether Molson Coors Beverage is a value opportunity hiding in plain sight or a stock that is cheap for a reason, you are in the right place. The share price has drifted lower, down about 3.0% over the last week, 2.6% over the past month, and a much steeper 21.1% year to date. This naturally raises questions about whether the market is getting overly pessimistic or finally catching up with reality. Those moves are playing out against a backdrop of shifting beer demand...

Shoe Carnival (SCVL) just posted Q3 2026 results with revenue of about $297 million and EPS of roughly $0.54, while net income came in at around $14.6 million and same store sales growth was a negative 2.7%, setting a cautious tone for the quarter. The company has seen quarterly revenue move from about $306.9 million and EPS of roughly $0.71 in Q3 2025 to $297.2 million and $0.54 in Q3 2026, with trailing 12 month revenue holding just above $1.1 billion and EPS a little over $2.12, so...

Dominion Energy recently reported better-than-expected Q3 2025 adjusted earnings and revenue, narrowed its full‑year operating guidance, and continued advancing its large capital program, including the Coastal Virginia Offshore Wind project, while receiving regulatory approvals for new infrastructure and rate changes benefiting high‑load customers like data centers. This combination of cleaner energy build‑out, AI‑driven data center demand, and new rate structures is reshaping Dominion’s...

uniQure (NasdaqGS:QURE) just hit a key regulatory speed bump, with the FDA signaling that current Phase I/II data for its AMT-130 Huntington’s program likely will not carry a Biologics License Application. See our latest analysis for uniQure. The setback has hit sentiment hard in the short term, with a 1 week share price return of minus 22.46 percent and a 30 day share price return of minus 23.25 percent. However, momentum is still positive versus earlier in the year given a 90 day share...

Rush Enterprises (RUSH.A) just rolled out a fresh $150 million share repurchase program after nearly maxing out its prior plan, signaling management’s confidence in free cash flow and long term resilience despite a tougher truck cycle. See our latest analysis for Rush Enterprises. The new buyback and recent bylaw refresh come as the stock has bounced, with a 30 day share price return of 12.52 percent but a softer 1 year total shareholder return of negative 10.07 percent, suggesting long term...

If you are wondering whether Baxter International at around $18.54 is a bargain or a value trap, you are not alone. That is exactly what this breakdown is going to unpack. The stock has slipped 1.1% over the last week but is up 3.0% over the past month, while still sitting on steep losses of 36.6% year to date and 40.6% over the last year. This has many investors questioning whether the risk profile has finally shifted. Recent headlines have focused on Baxter reshaping its portfolio and...

Applied Digital (APLD) has been in the spotlight after locking in long term leases with major hyperscalers, fully energizing its first Polaris Forge 1 building, and backing Corintis for next gen chip cooling. See our latest analysis for Applied Digital. Those execution wins have not gone unnoticed, with a 90 day share price return of 124.44 percent and a year to date share price return of 300.26 percent signaling powerful momentum. The 1 year total shareholder return of 192.60 percent...

Domo (DOMO) just dropped a double header: a leadership shift as CEO Joshua James scales back duties for health reasons and CTO Daren Thayne steps in as interim principal executive, alongside fresh quarterly results and guidance. See our latest analysis for Domo. The leadership news and earnings update come after a sharp reset in sentiment, with a 1 month share price return of minus 30.05 percent and a 3 year total shareholder return of minus 49.69 percent, signalling fading momentum despite...

In late November 2025, Perrone Robotics filed patent infringement lawsuits against Tesla and six other automakers, while Tesla’s operations, robotics ambitions, product updates, and regional sales trends continued to evolve through early December, including new Model 3 pricing in Europe and mixed demand signals across key markets. At the same time, Tesla’s growing focus on humanoid robots, in‑house AI chips, and supportive U.S. robotics policy is shifting the company’s story further away...

Dell Technologies (DELL) has quietly become a long term winner, with the stock up about 190% year to date and more than tripling over the past 3 years despite recent pullbacks. See our latest analysis for Dell Technologies. At around $138.91, Dell’s recent 7 day share price return of just over 4% comes after a softer 30 day patch. However, the 3 year total shareholder return above 250% shows the longer term momentum story is still very much intact. If Dell’s run has you thinking about what...

The spotlight on Guardant Health (GH) really brightened after its third quarter update, which paired strong revenue growth with upbeat analyst commentary and fresh capital raises that underline management’s confidence in funding the next leg of expansion. See our latest analysis for Guardant Health. Those upbeat third quarter numbers and capital raises have landed against a backdrop of powerful momentum, with Guardant Health’s 90 day share price return of nearly 70 percent and a 1 year total...

Why Medtronic Stock Is Back on Investors Radar Medtronic (MDT) has quietly pushed higher this year, and the latest leg of its move has less to do with headlines and more to do with investors revisiting its steady earnings and dividend profile. See our latest analysis for Medtronic. After a strong run this year, the share price has cooled slightly in recent days. However, a roughly 10% 1 month share price return and robust multi year total shareholder returns suggest momentum is gradually...

Twilio recently reported strong third-quarter 2025 results under new CEO Khozema Shipchandler, highlighting 15% revenue growth, 23% non-GAAP EPS growth, robust free cash flow, and a raised full-year revenue outlook, while also acquiring AI-based identity platform Stytch and disclosing a US$129 million insider share sale by Director Andrew Stafman and related parties. Together, the business rebound, focused push into AI-enhanced customer engagement, and sizable insider transaction give...

MSCI has launched the MSCI All Country Public + Private Equity Index, a daily benchmark that blends the MSCI ACWI IMI with a new private equity index built from LP-sourced data on nearly 10,000 funds, targeting a 15% allocation to modelled private equity and rebalancing quarterly. This hybrid index gives investors a single framework to view public and private equity exposures together, potentially reshaping how institutions benchmark diversified, total-portfolio equity allocations. Next,...